Exemestane 25 mg Astera Labs is an important medication in the field of oncology, specifically for the treatment of hormone-receptor-positive breast cancer. The understanding of its pharmacological action is crucial for both healthcare professionals and patients alike.
Exemestane 25 mg Astera Labs is a medication that is commonly used in the treatment of breast cancer. It belongs to a class of drugs known as aromatase inhibitors, which work by reducing the production of estrogen in the body. By lowering estrogen levels, Exemestane helps to slow down or stop the growth of hormone-receptor-positive breast cancer cells. For more information about Exemestane 25 mg Astera Labs, please visit Exemestane 25 mg Astera Labs.
Mechanism of Action
Exemestane functions primarily through the following mechanisms:
- Aromatase Inhibition: Exemestane irreversibly binds to the aromatase enzyme, preventing the conversion of androgens to estrogens.
- Estrogen Deprivation: By lowering estrogen levels, Exemestane deprives estrogen-dependent tumors of the hormone they need to grow.
- Selective Estrogen Receptor Modulation: Exemestane may also act on estrogen receptors, providing an additional layer of action against breast cancer.
Indications for Use
Exemestane is primarily indicated for:
- Adjuvant treatment of postmenopausal women with hormone-receptor-positive early breast cancer.
- Treatment of advanced breast cancer in postmenopausal women whose disease has progressed after previous anti-estrogen therapy.
Side Effects and Considerations
While Exemestane is generally well-tolerated, it can have side effects, including:
- Hot flashes
- Fatigue
- Joint pain
- Increased risk of osteoporosis
Patients should discuss potential risks and benefits with their healthcare provider prior to initiating treatment with Exemestane.
